Zagum Bhatti, MD
Vascular & Interventional Radiology · Port Authur, TXNPI 1053577890
Payments from drug & device makers
What this record shows
The money is spread across several categories — other (33.2%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 23 manufacturers reported payments, led by Angiodynamics, Inc. at 43.8% of the total. 2025 is the largest year on record at $32,220, 7.0 times the $4,635 reported in 2019. Among vascular & interventional radiology clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 298 payments — averaging $301.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Angiodynamics, Inc.$39K
- Cook Incorporated$35K
- Boston Scientific$6K
- Medtronic$2K
- Cook Medical LLC$1K
- Astrazeneca UK Limited$1K
- plus $4K from 17 others
What the payments were for
- Consulting fees$7,2458%
- Speaking & faculty fees$28,23031%
- Travel & lodging$6,4327%
- Food & beverage$9,82111%
- Education$8,2509%
- Other$29,75033%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Angiodynamics, Inc. | 40 | $39,273 |
| Cook Incorporated | 17 | $35,429 |
| Boston Scientific | 96 | $6,044 |
| Medtronic | 25 | $2,010 |
| Cook Medical LLC | 26 | $1,252 |
| Astrazeneca UK Limited | 11 | $1,226 |
| Biocompatibles, Inc. | 9 | $1,198 |
| Inari Medical, Inc. | 8 | $776 |
| Sirtex Medical Inc | 14 | $685 |
| Bard Peripheral Vascular, Inc. | 8 | $506 |
| Globus Medical | 4 | $299 |
| Veryan Medical Incorporated | 6 | $216 |
| W. L. Gore & Associates, Inc. | 3 | $202 |
| Johnson & Johnson | 20 | $153 |
| Philips North America LLC | 1 | $113 |
| Penumbra, Inc. | 1 | $104 |
| Abbott | 2 | $99 |
| Siemens Medical Solutions USA, Inc. | 2 | $37 |
| Asahi Intecc USA, Inc. | 1 | $36 |
| Avinger Inc. | 1 | $21 |
| GE HealthCare | 1 | $19 |
| Cardiovascular Systems Inc. | 1 | $19 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Auryon Laser System 100-120 Vac$38,346
- Tornado$18,254
- Torcon NB$13,398
- Cook$2,559
- THERASPHERE-BIO$2,262
- Nester$1,470
- JETSTREAM SC$1,095
- Ellipsys$1,003
- GENERAL - THERAPIES$666
- FLOWTRIEVER CATHETER, S$541
- CT THROMBECTOMY SYSTEM KIT$541
- SIR-Spheres Microspheres$422
- Palindrome$385
- ROSEN$154
- VIATORR TIPS Endoprosthesis with Controlled Expansion$138
- THERASPHERE$124
- HawkOne$121
- GENERAL EMBOLICS$120
- GENERAL VASCULAR INTERVENTION$118
- (5027) Intact Vascular Und$113
How this compares
$89,728 in reported general payments places this provider in the 90th percentile of 299 vascular & interventional radiology providers in Texas.
See all vascular & interventional radiology providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 25 | $20,436 |
| EliquisApixaban | 13 | $12,951 |
| ClopidogrelClopidogrel Bisulfate | 83 | $614 |
| Methylprednisolone | 32 | $238 |
| Ciprofloxacin Hcl | 28 | $178 |
| Naproxen | 34 | $103 |
| Prednisone | 12 | $5 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $153 | $20,43625 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 299 vascular & interventional radiology providers in Texas.
Other vascular & interventional radiology in Port Authur
- Orlando DiazHouston$611K
- Rahul ShethHouston$410K
- Miguel MonteroHouston$386K
- Joshua KubanHouston$301K
- Peiman HabibollahiHouston$254K
- Ahmed Abdel AalHouston$147K
- Varshana GurusamyHouston$141K
- Sanjeeva KalvaDallas$128K
- Mehrzad ZarghouniBellaire$127K
- John FitzsimonsGarland$127K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.